Stay updated on Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Page revision updated from v3.3.3 to v3.3.4. No substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-01-14T03:06:04.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    A dedicated Locations section has been added, listing Washington (Seattle, Washington) as a study site.
    Difference
    0.2%
    Check dated 2025-12-23T21:22:03.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Minor, non-substantive wording updates to the PubMed publications note and revision version indicators, replacing an explanatory sentence with a clarified version and updating the revision tag from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:43:39.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    The banner notice about government funding and operating status has been removed from the page, and the study details are presented without that disclaimer.
    Difference
    0.4%
    Check dated 2025-11-18T06:55:53.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    No substantial changes to core content, critical elements, or user actions were detected; observed differences appear to be cosmetic formatting or minor text edits.
    Difference
    0.4%
    Check dated 2025-11-03T20:56:57.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    Upgrade to version v3.2.0 with an important government funding and operating status notice; removal of the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T05:16:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Doxorubicin in Sarcoma Clinical Trial page.